Craig Wong-Pan's Stock Ratings

RBC Capital Analyst

Craig Wong-Pan is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/23/2024

Overall Average Return

10.6%

Smart Score

69.6%

Overall Average Return Percentile

61st

Number of Ratings

14
Buy NowGet Alert
07/23/2024RMDBuy Now
ResMed
$206.53-1.23%$200 → $204MaintainsSector PerformGet Alert
04/26/2024RMDBuy Now
ResMed
$206.53-3.16%$187 → $200MaintainsSector PerformGet Alert
01/25/2024RMDBuy Now
ResMed
$206.53-11.88%$181 → $182MaintainsSector PerformGet Alert
10/12/2023RMDBuy Now
ResMed
$206.53-2.2%$273 → $202DowngradeOutperform → Sector PerformGet Alert
08/14/2023RMDBuy Now
ResMed
$206.5332.18%$284 → $273MaintainsOutperformGet Alert
08/04/2023RMDBuy Now
ResMed
$206.5337.51% → $284ReiteratesOutperform → OutperformGet Alert
08/01/2023RMDBuy Now
ResMed
$206.5337.51%$262 → $284UpgradeSector Perform → OutperformGet Alert
10/28/2022RMDBuy Now
ResMed
$206.5322.98%$252 → $254MaintainsSector PerformGet Alert
08/12/2022RMDBuy Now
ResMed
$206.5322.01%$246 → $252DowngradeOutperform → Sector PerformGet Alert
06/15/2022RMDBuy Now
ResMed
$206.5319.59%$244 → $247MaintainsOutperformGet Alert
06/06/2022RMDBuy Now
ResMed
$206.5318.14%$233 → $244UpgradeSector Perform → OutperformGet Alert
04/29/2022RMDBuy Now
ResMed
$206.5312.81%$241 → $233MaintainsSector PerformGet Alert
01/28/2022RMDBuy Now
ResMed
$206.5316.69% → $241UpgradeUnderperform → Sector PerformGet Alert
01/13/2022RMDBuy Now
ResMed
$206.5313.3%$227 → $234MaintainsUnderperformGet Alert